Unknown

Dataset Information

0

Ceramide: improving Bcl-2 inhibitor therapy.

ABSTRACT:

SUBMITTER: Barth BM 

PROVIDER: S-EPMC9247366 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Ceramide: improving Bcl-2 inhibitor therapy.

Barth Brian M BM  

Blood 20220601 26

Similar Datasets

Unknown Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia.
| S-EPMC9642852 | biostudies-literature
Unknown Anti-apoptotic Bcl-2 Family Proteins Disassemble Ceramide Channels.
| S-EPMC2713582 | biostudies-literature
Unknown Ceramide channels: destabilization by Bcl-xL and role in apoptosis.
| S-EPMC4554889 | biostudies-literature
Unknown Proapoptotic Bcl-2 inhibitor as potential host directed therapy for pulmonary tuberculosis.
| S-EPMC11950383 | biostudies-literature
Unknown Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy.
| S-EPMC2631952 | biostudies-literature
Unknown Regulation of mitochondrial ceramide distribution by members of the BCL-2 family.
| S-EPMC4513991 | biostudies-literature
Unknown Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.
| S-EPMC8280112 | biostudies-literature
Unknown Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.
| S-EPMC3992626 | biostudies-literature
Unknown A chemoenzymatic synthesis of ceramide trafficking inhibitor HPA-12.
| S-EPMC6404422 | biostudies-literature
Unknown Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy.
| S-EPMC8277842 | biostudies-literature